معرفی
Robert Friedman is a Professor of Biotechnology Management at the Katz School of Science and Health, Yeshiva University. He brings extensive industry experience in Life Sciences, having held executive roles in finance and consulting across pharmaceuticals, biotechnology, medical technology, and diagnostics. Previously, he served in senior positions at firms like Navigant Consulting and Lehman Brothers, and held board roles at early-stage biopharmaceutical companies.
Education: BA from Yeshiva University, MBA from Cornell University’s Johnson Graduate School of Management.
His teaching emphasizes integrating scientific expertise with business management to address challenges in the evolving biotech industry. Courses focus on product value chain analysis in Life Sciences, covering discovery to commercialization, and draw insights from pharmaceuticals, medical devices, and diagnostics sectors.
No specific scientific awards or grants are listed in the provided materials. His professional experience spans over 30 years with roles at IBM Consulting, The Wilkerson Group, and Kidder Peabody.
